McLaren Flint: No pharmacy products bought at N.E. Compounding Center

FLINT — With national attention focused on the rise of fungal meningitis cases associated with tainted steroid injections, McLaren Flint is assuring patients it has not purchased or used any of the products that have been recalled or linked to these incidents nor has the McLaren Flint medical center ever done business with the New England Compounding Center (NECC) in Framingham, Mass.

The meningitis outbreak is associated with the compounded preservative-free agent methylprednisolone (80 mg/mL), which was manufactured by New England Compounding Center (NECC) in Framingham, Mass.

Recently, a pharmacy affiliated with NECC, Ameridose LLC, temporarily ceased production of all products at its facilities in Westborough, Mass., pending a full FDA inspection due to the common ownership of the two companies.

On Oct. 16, the FDA updated their patient notification recommendations to include ANY injectable medication from NECC, including injectable ophthalmic drugs used in conjunction with eye surgery, or cardioplegic solution purchased from or produced by NECC after May 21, 2012.

Since McLaren Flint confirms it has never purchased any products from New England Compounding Center, the medical center and its patients have no exposure to any of these products, officials at McLaren said. — G.G.

Leave a Reply

Your email address will not be published. Required fields are marked *